Copyright©IBMI&RBMP. To share this article, please indicate the source or include a link back to it.
- The currency used in this article is Taiwan Dollar (TWD).
- The number of biomedical companies registered, including the agricultural technology segment, companies with listed, unlisted and emerging stocks, are 205.
- Revenue in Q1, 2022 totalled TWD$76.4B, up by 4.1% as opposed to $73.4B the same quarter in 2021.
Biomedical Sector by Revenue in Q1, with Listed, Unlisted and Emerging Stocks Combined, 2021-2022
| Business Focus / Income Stream |
Q1, 2022 |
Q1, 2021 |
QoQ Growth (%) |
| No. of Company |
Revenue
(TWD, 1B)
|
Average Revenue (TWD, 1B) |
Revenue
(TWD, 1B)
|
Top 20 by Revenue: Q1, 2022
Top 20 by Revenue Growth in Q1, 2022: Listed Company
Top 20 by Revenue Growth in Q1, 2022: OTC Company
Top 20 by Revenue Growth in Q1, 2022: Emerging Stock (Taipei Exchange)
Source: MOPS, complied by IBMI & RBMP
